Paxlovid – Talk Bio

Actionable Insights Powered by AI

Pfizer Boosts Revenue Forecast by $1.5 Billion Amid Paxlovid Rebound, Despite Criticism from Starboard

6 months ago talkbio0Tagged COVID19 (disease), financial performance, Paxlovid, Pfizer, Starboard

Pfizer, revenue outlook, Paxlovid, Starboard, pharmaceuticals, COVID-19, financial performance

Paxlovid did not beat placebo in Stanford-led long Covid study

11 months ago talkbio0Tagged Paxlovid, Placebos, Symptoms aspect

Paxlovid, Symptoms aspect, Placebos